Phoenix and Raven launch direct-to-patient generic semaglutide after Health Canada approval
Generic semaglutide is cheaper, but access is now the real battleground. Phoenix and Raven are testing Canada’s GLP-1 telehealth future.
Pharma & Biotech
Medical Devices & Diagnostics
TytoCare just opened a new FDA category. Can AI make home ear exams clinically useful?
Home diagnostics need regulatory trust. TytoCare’s FDA De Novo win tests whether AI can move ear exams beyond video visits.
Medical Devices & Diagnostics
Why the Ro and Eli Lilly KwikPen move matters for obesity drug access, adherence, and pricing
Ro launches Eli Lilly’s Zepbound KwikPen nationwide. Read what this means for GLP-1 access, pricing, adherence, and obesity care models.
Pharma & Biotech
Why the Syra Health and Nora Mental Health deal matters for telebehavioral care in Indiana
Syra Health and Nora Mental Health are linking AI triage with teletherapy in Indiana. Read why this could reshape digital mental health access.
Pharma & Biotech
Brello Rise enters the obesity care landscape as a digital wellness adjunct to medical weight loss
Brello Health launches Brello Rise, a digital studio for patients in medical weight loss programs. Find out what this signals for obesity care models.
Medical Devices & Diagnostics
Why Q Care Plus is blending PrEP, birth control, and sexual health in one telehealth platform
Q Care Plus adds ED, hair loss, and birth control services to its virtual platform. Find out how this reshapes stigma-free access to sexual wellness care.
Medical Devices & Diagnostics
Why 60 Degrees Pharmaceuticals is betting on Runway Health to reshape malaria prevention access
Discover how 60 Degrees Pharmaceuticals is using telehealth to expand ARAKODA access and what this shift means for malaria prevention strategy.